Ratings National Health Investors, Inc.

Equities

NHI

US63633D1046

Market Closed - Nyse Other stock markets 04:00:02 2024-05-13 pm EDT			5-day change	1st Jan Change
65.86 ^USD	+0.86%		+2.51%	+17.92%

May. 09	Land & Buildings Investment Management Comments on National Health Investors? Supplemental Proxy Statement	CI
May. 07	Transcript : National Health Investors, Inc., Q1 2024 Earnings Call, May 07, 2024

Strengths

The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
The company is one of the best yield companies with high dividend expectations.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Analyst opinion has improved significantly over the past four months.
There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.

Weaknesses

The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
The company benefits from high valuations in earnings multiples.
The company's "enterprise value to sales" ratio is among the highest in the world.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialized REITs

	1st Jan change	Capi.	ESG Refinitiv
NATIONAL HEALTH INVESTORS, INC.	+17.92%	2.84B	C-
WELLTOWER INC.	+10.32%	59.09B	A-
VENTAS, INC.	-4.47%	19.25B	A-
OMEGA HEALTHCARE INVESTORS, INC.	+0.26%	7.58B	B
HEALTHCARE REALTY TRUST INCORPORATED	-7.08%	5.82B	B-
CARETRUST REIT, INC.	+10.77%	3.51B	C-
SABRA HEALTH CARE REIT, INC.	+1.54%	3.36B	C+
AEDIFICA SA	-1.73%	3.22B	B+
MEDICAL PROPERTIES TRUST, INC.	+13.65%	2.87B	C
COFINIMMO	-15.69%	2.62B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes